18:00 Uhr - 19:00 Uhr
Zoonotic viruses that cross the species barrier can induce severe disease in humans and are of great concern to public health. Recent evidence of the dramatic consequences such events might have is the Ebola virus outbreak in West Africa which caused more than 11 thousand deaths and threatened to destabilize a whole region
Only unprecedented international efforts were able to finally contain this outbreak. This outbreak showed the crucial need to produce antivirals and specific preventive vaccines also for the rare highly pathogenic viruses of no commercial interest. Those pathogens might have a strong impact on the health care systems of resource limited countries and are also difficult to manage in developed countries. It is therefore necessary to develop strategies that aim at improving our preparedness to fight those neglected tropical diseases. The House of Pharma lectures will address the question of how public-privatepartnership can support the development and production of emergency vaccines against Ebola and other emerging viruses.
Prof. Dr. Stephan Becker, Institut für Virologie, Philipps-Universität Marburg
Francois P. Roman, MD, PhD, Clinical and Epidemiological Project Lead, GlaxoSmithKline Vaccines, Belgium